Open AccessPembrolizumab as a first-line therapy in spinocellular esophageal cancer
Author(s) -
Ľudmila Křížová,
František Charvát,
Luboš Petruželka
Publication year - 2021
Publication title -
klinická onkologie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.204
H-Index - 13
eISSN - 1802-5307
pISSN - 0862-495X
DOI - 10.48095/ccko202159
Subject(s) - pembrolizumab , medicine , esophagus , oncology , immunotherapy , esophageal cancer , chemotherapy , cancer , disease